Product Code: ETC13287153 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global AI Drug Discovery Market was valued at USD 2.9 Billion in 2024 and is expected to reach USD 11.1 Billion by 2031, growing at a compound annual growth rate of 19.88% during the forecast period (2025-2031).
The Global AI Drug Discovery Market is experiencing significant growth driven by the increasing need for innovative solutions in drug development. AI technologies such as machine learning and deep learning are being utilized to accelerate the process of drug discovery by analyzing vast amounts of data to identify potential drug candidates with higher efficiency and accuracy. The market is characterized by collaborations between pharmaceutical companies and AI startups, as well as investments in AI-driven drug discovery platforms. Factors such as the rising prevalence of chronic diseases, growing demand for personalized medicine, and advancements in AI algorithms are expected to propel the market further. However, challenges related to data privacy, regulatory hurdles, and the need for skilled professionals in AI and drug development remain key concerns for market growth.
The Global AI Drug Discovery Market is experiencing rapid growth due to advancements in artificial intelligence technologies and the increasing demand for innovative drug development solutions. Key trends include the integration of machine learning algorithms for predicting drug-target interactions, the use of deep learning models for virtual screening, and the application of AI in drug repurposing efforts. Opportunities in the market lie in the development of personalized medicine through AI, the growth of AI-driven platforms for data analysis and interpretation, and the increasing collaborations between pharmaceutical companies and AI startups. As the pharmaceutical industry continues to face challenges in drug discovery, AI technologies offer promising solutions to accelerate the process, reduce costs, and enhance the success rate of bringing new drugs to market.
The Global AI Drug Discovery Market faces several challenges, including data quality and availability issues, regulatory uncertainties, and the need for skilled professionals to develop and implement AI algorithms effectively. Data in the pharmaceutical industry can be complex and heterogeneous, making it challenging to ensure the quality and relevance of the data used for AI-driven drug discovery processes. Additionally, regulatory bodies are still evolving their guidelines for AI applications in drug development, leading to uncertainties and roadblocks for companies. Moreover, there is a shortage of individuals with the necessary expertise in both AI and pharmaceutical science to harness the full potential of AI in drug discovery, highlighting the need for further training and education in this interdisciplinary field. Overcoming these challenges will be crucial for the successful integration of AI technologies in drug discovery processes.
The Global AI Drug Discovery Market is primarily driven by the increasing need for novel and more efficient drug development solutions to address complex diseases and reduce the time and cost involved in the drug discovery process. AI technologies offer the potential to accelerate drug discovery by leveraging big data analytics, machine learning algorithms, and predictive modeling to identify drug candidates with higher success rates. Additionally, the rising adoption of AI-powered platforms by pharmaceutical companies, biotech firms, and research institutions to expedite the drug discovery process further propels market growth. The ability of AI to analyze vast amounts of biological data, predict drug-target interactions, and optimize clinical trial design is reshaping the pharmaceutical industry and driving the demand for AI-driven drug discovery solutions worldwide.
Government policies related to the Global AI Drug Discovery Market vary by country, with many governments investing in initiatives to promote the use of artificial intelligence (AI) in drug discovery. For example, the US government has established programs like the FDA`s Emerging Technology Program to support the evaluation of AI technologies in drug development. In China, the government has launched the "New Generation Artificial Intelligence Development Plan" to accelerate the adoption of AI in various industries, including pharmaceuticals. Additionally, the European Union has initiatives such as the European AI Alliance to promote the responsible and ethical use of AI in drug discovery. Overall, governments worldwide are recognizing the potential of AI in revolutionizing the drug discovery process and are implementing policies to support its integration into the healthcare industry.
The Global AI Drug Discovery Market is poised for significant growth in the coming years, driven by the increasing adoption of artificial intelligence technology in the pharmaceutical industry. AI offers the potential to accelerate drug discovery processes, reduce costs, and improve the success rate of drug development. The market is expected to witness a surge in investments in AI-driven drug discovery platforms and tools, leading to a more efficient and streamlined drug development pipeline. With the rising prevalence of chronic diseases and the need for novel treatments, AI is set to play a crucial role in revolutionizing drug discovery and shaping the future of healthcare. Overall, the Global AI Drug Discovery Market is expected to experience robust growth and innovation in the foreseeable future.
In the Global AI Drug Discovery Market, Asia is experiencing rapid growth due to the increasing investment in AI technologies by pharmaceutical companies and research institutions. North America remains a dominant player, driven by strong government support, advanced healthcare infrastructure, and a high adoption rate of AI solutions. Europe is witnessing significant advancements in AI drug discovery, supported by collaborations between academia, industry, and government bodies. The Middle East and Africa region is gradually embracing AI technologies in drug discovery, with a focus on developing personalized medicine. Latin America is also showing potential for growth, with a rise in partnerships between pharmaceutical companies and AI startups to enhance drug development processes. Overall, these regional insights highlight the global expansion and adoption of AI in drug discovery, with each region contributing to the market`s evolution.
Global AI Drug Discovery Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global AI Drug Discovery Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global AI Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Global AI Drug Discovery Market - Industry Life Cycle |
3.4 Global AI Drug Discovery Market - Porter's Five Forces |
3.5 Global AI Drug Discovery Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global AI Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.7 Global AI Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global AI Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.9 Global AI Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global AI Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global AI Drug Discovery Market Trends |
6 Global AI Drug Discovery Market, 2021 - 2031 |
6.1 Global AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global AI Drug Discovery Market, Revenues & Volume, By Software, 2021 - 2031 |
6.1.3 Global AI Drug Discovery Market, Revenues & Volume, By Services, 2021 - 2031 |
6.2 Global AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global AI Drug Discovery Market, Revenues & Volume, By Target Identification, 2021 - 2031 |
6.2.3 Global AI Drug Discovery Market, Revenues & Volume, By Drug Screening, 2021 - 2031 |
6.2.4 Global AI Drug Discovery Market, Revenues & Volume, By Lead Optimization, 2021 - 2031 |
6.2.5 Global AI Drug Discovery Market, Revenues & Volume, By Preclinical Testing, 2021 - 2031 |
6.3 Global AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global AI Drug Discovery Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.3.3 Global AI Drug Discovery Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.3.4 Global AI Drug Discovery Market, Revenues & Volume, By Immunology, 2021 - 2031 |
6.3.5 Global AI Drug Discovery Market, Revenues & Volume, By Cardiovascular, 2021 - 2031 |
6.4 Global AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global AI Drug Discovery Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 Global AI Drug Discovery Market, Revenues & Volume, By Biotechnology Companies, 2021 - 2031 |
6.4.4 Global AI Drug Discovery Market, Revenues & Volume, By Academic Institutions, 2021 - 2031 |
6.4.5 Global AI Drug Discovery Market, Revenues & Volume, By Contract Research Organizations, 2021 - 2031 |
7 North America AI Drug Discovery Market, Overview & Analysis |
7.1 North America AI Drug Discovery Market Revenues & Volume, 2021 - 2031 |
7.2 North America AI Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.3 North America AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
7.4 North America AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6 North America AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) AI Drug Discovery Market, Overview & Analysis |
8.1 Latin America (LATAM) AI Drug Discovery Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) AI Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
8.4 Latin America (LATAM) AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
8.6 Latin America (LATAM) AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia AI Drug Discovery Market, Overview & Analysis |
9.1 Asia AI Drug Discovery Market Revenues & Volume, 2021 - 2031 |
9.2 Asia AI Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
9.4 Asia AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
9.6 Asia AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa AI Drug Discovery Market, Overview & Analysis |
10.1 Africa AI Drug Discovery Market Revenues & Volume, 2021 - 2031 |
10.2 Africa AI Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
10.4 Africa AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
10.6 Africa AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe AI Drug Discovery Market, Overview & Analysis |
11.1 Europe AI Drug Discovery Market Revenues & Volume, 2021 - 2031 |
11.2 Europe AI Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
11.4 Europe AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
11.6 Europe AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East AI Drug Discovery Market, Overview & Analysis |
12.1 Middle East AI Drug Discovery Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East AI Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey AI Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East AI Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
12.4 Middle East AI Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East AI Drug Discovery Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
12.6 Middle East AI Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global AI Drug Discovery Market Key Performance Indicators |
14 Global AI Drug Discovery Market - Export/Import By Countries Assessment |
15 Global AI Drug Discovery Market - Opportunity Assessment |
15.1 Global AI Drug Discovery Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global AI Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
15.3 Global AI Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global AI Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
15.5 Global AI Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global AI Drug Discovery Market - Competitive Landscape |
16.1 Global AI Drug Discovery Market Revenue Share, By Companies, 2024 |
16.2 Global AI Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |